News

Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.
The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...
Novavax (NVAX) closed the most recent trading day at $6.61, moving -2.79% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.79% for the day. At the ...
The stock's fall snapped a three-day winning streak.
This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
Senior officials at the Food and Drug Administration appointed by the Trump administration, under Health and Human Services ...
FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...